Valery Radchenko
2036 Main Mall, V6T 1Z1
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 86 publications
Recycling-compatible electroplating of enriched tin-119 targets for the production of antimony-119 for targeted Auger electron therapy.
Journal: EJNMMI radiopharmacy and chemistry
Published: May 14, 2026
Panitumumab labeled with Auger electron-emitting 197gHg/197mHg: cytotoxicity on human breast cancer cells and tumour and normal tissue uptake in mice with EGFR-overexpressing breast cancer xenografts.
Journal: EJNMMI radiopharmacy and chemistry
Published: February 06, 2026
Treatment of Human Glioblastoma Multiforme in NRG Mice by Convection-Enhanced Delivery of EGFR-Targeted or Nontargeted Auger Electron-Emitting 197gHg-Labeled Gold Nanoparticles.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: December 01, 2025
Modeling the yields of225Ra/225Ac and the resulting225Ac radioisotopic purity from proton irradiation of232Th at 100-800 MeV.
Journal: Physics in medicine and biology
Published: August 01, 2025
Quantitative dual-isotope preclinical SPECT/CT imaging and biodistribution of the mercury-197m/g theranostic pair with [197m/gHg]HgCl2 and a [197m/gHg]Hg-tetrathiol complex as a platform for radiopharmaceutical development.
Journal: EJNMMI radiopharmacy and chemistry
Published: July 29, 2025
Theoretical optimal232Th target thicknesses for225Ac production at proton energies of 70-200 MeV.
Journal: Physics in medicine and biology
Published: May 09, 2025
Auger electron-emitting EGFR-targeted and non-targeted [197Hg]Hg-gold nanoparticles for treatment of glioblastoma multiforme (GBM).
Journal: EJNMMI radiopharmacy and chemistry
Published: May 01, 2025
Developing ether and alcohol based extraction chromatography resins for purification of antimony-119 in nuclear medicine.
Journal: EJNMMI radiopharmacy and chemistry
Published: April 25, 2025
Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3.
Journal: Nuclear medicine and biology
Published: April 16, 2025
Corrigendum to "Alpha Atlas: Mapping global production of α-emitting radionuclides for targeted alpha therapy" [Nucl Med Biol (March-April 2025) 108990].
Journal: Nuclear medicine and biology
Published: March 18, 2025
Novel dibutyl ether resin for the purification of the Auger emitter antimony-119 from tin targets.
Journal: Nuclear medicine and biology
Published: February 10, 2025
Potent candidates for Targeted Alpha Therapy (TAT).
Journal: Nuclear medicine and biology
Published: December 01, 2024
Last Updated: 09/26/2026